ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,769Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 315

$536K Total Retail Price of All Prescriptions

Rank: 60 out of 315

369 Patients Receiving at Least One Drug in Part D
51%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 369 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 369 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 4,143 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LISINOPRIL 527 261 1 3
SIMVASTATIN 478 305 2 1
METFORMIN HCL 333 148 3 7
HYDROCODONE-ACETAMINOPHEN 297 118 S3 4 19
LOSARTAN POTASSIUM 197 134 5 4
AMLODIPINE BESYLATE 192 129 6 2
HYDROCHLOROTHIAZIDE 189 125 7 16
FUROSEMIDE 169 75 8 15
LOVASTATIN 164 98 9 8
METOPROLOL TARTRATE 163 97 10 18
METOPROLOL SUCCINATE 144 117 11 13
ATORVASTATIN CALCIUM 143 92 12 5
OMEPRAZOLE 141 81 13 9
RANITIDINE HCL 133 56 14 42
LEVOTHYROXINE SODIUM 131 85 15 6
ALLOPURINOL 120 50 16 14
WARFARIN SODIUM 110 85 17 20
DIOVAN 107 97 18 27
GABAPENTIN 99 39 19 37
GLIPIZIDE 86 28 20 30
MORPHINE SULFATE ER 86 35 S2 20 128
OXYCODONE HCL 85 31 S2 22 57
ALENDRONATE SODIUM 79 50 23 12
VENTOLIN HFA 78 33 24 173
PROAIR HFA 78 51 24 52
ATENOLOL 77 69 26 11
GLIPIZIDE ER 74 44 27 55
CLOPIDOGREL 70 42 28 25
ADVAIR DISKUS 69 56 29 46
FELODIPINE ER 68 43 30 23
CARVEDILOL 65 57 31 22
LANTUS SOLOSTAR 64 35 32 69
PLAVIX 63 43 33 40
COLCRYS 62 32 34 85
TRAMADOL HCL 61 42 35 59
POTASSIUM CHLORIDE 54 35 36 36
PEN NEEDLE 52 30 37 91
GLIMEPIRIDE 50 21 38 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.